For the Inventor, By the Inventor

Enter inventor name

Daegu, South Korea

Sae Kwang Ku

USPTO Granted Patents = 15 (Patent Applications = 9)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 7(Granted Patents)

Location History:

Suwon-si, KR (2011 - 2012)
Daegu, KR (2016 - 2022)

Company Filing History:

Comprehensive and Integrative Medicine Institute

Dong Wha Pharmaceutical Co. Ltd.

Okchundang Co., Ltd.

Aribio Co., Ltd.

5. 2 out of 200

Sk Chemicals Co., Ltd.

where one patent can have more than one assignee

Years Active: 2011-2022

Loading Chart...

Loading Chart...

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11235018 - Composition for preventing or treating cancer (2022-02-01),

2. 11129861 - Methods for treating inflammatory diseases (2021-09-28),

3. 11065294 - Composition including oriental medicine to treat neoplastic disease (2021-07-20),

4. 10765647 - Composition for treating diabetes, containing extract of yukmijihwangtang (2020-09-08),

5. 10695394 - Composition containing herbal medicine extracts of Pinellia and Scutellaria for reducing side effects due to anticancer drugs (2020-06-30),

6. 10342835 - Composition containing angelica extract for promoting proliferation of stem cells derived from bone marrow (2019-07-09),

7. 10286040 - Composition containing palmultang extract for promoting proliferation of stem cells derived from bone marrow (2019-05-14),

8. 10265333 - Lipid nanomaterial containing lysophosphatidylcholine or derivative thereof and method for preparing same (2019-04-23),

9. 10064865 - Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells (2018-09-04),

10. 9750743 - Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells (2017-09-05),

11. 9446061 - Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections (2016-09-20),

12. 8324238 - Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same (2012-12-04),

13. 8178688 - Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same (2012-05-15),

14. 7943646 - Benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising same (2011-05-17),

15. 7923443 - Pharmaceutical composition for the treatment of bone fracture (2011-04-12),

Title: Sae Kwang Ku: Innovator in Pharmaceutical Composition

Introduction

Sae Kwang Ku is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in compositions aimed at treating serious health conditions. With a total of 15 patents to his name, his work has garnered attention for its innovative approaches to cancer treatment and inflammatory diseases.

Latest Patents

One of his latest patents is a composition for preventing or treating cancer. This invention provides a pharmaceutical composition that not only aims to prevent or treat cancer but also enhances immune functions and addresses cachexia caused by tumors. The composition is designed to inhibit tumor growth, increase immunological activity, and can achieve a synergistic effect when co-administered with existing anticancer drugs.

Another notable patent focuses on methods for treating inflammatory diseases. This invention includes a composition containing active ingredients for antitussive, expectorant, or anti-inflammatory actions. The composition is derived from natural materials and exhibits minimal cytotoxicity, making it a safe option for use as a medicine or food composition.

Career Highlights

Sae Kwang Ku has worked with various organizations, including the Comprehensive and Integrative Medicine Institute and Dong Wha Pharmaceutical Co. Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical compositions.

Collaborations

Throughout his career, Sae Kwang Ku has collaborated with notable colleagues, including Joon Seok Byun and Ki Cheul Sohn. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Sae Kwang Ku is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of cancer and inflammatory diseases. His innovative approaches and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…